相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Allodynia in Menstrually Related Migraine: Score Assessment by Allodynia Symptom Checklist (ASC-12)
Eliana Meire Melhado et al.
HEADACHE (2020)
A subjective cognitive impairments scale for migraine attacks: validation of the Italian version of the MIG-SCOG
Antonio Russo et al.
NEUROLOGICAL SCIENCES (2020)
Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy
Raffaele Ornello et al.
JOURNAL OF HEADACHE AND PAIN (2020)
Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA: A Dual-Center Retrospective Observational Study
Bianca Raffaelli et al.
FRONTIERS IN NEUROLOGY (2020)
Erenumab for Preventive Treatment of Migraine: A Systematic Review and Meta-Analysis of Efficacy and Safety
Simona Lattanzi et al.
DRUGS (2019)
Erenumab: from scientific evidence to clinical practicethe first Italian real-life data
Piero Barbanti et al.
NEUROLOGICAL SCIENCES (2019)
Efficacy and safety of erenumab (AMG334) in episodic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study
Peter J. Goadsby et al.
CEPHALALGIA (2019)
Pathophysiological Mechanisms in Migraine and the Identification of New Therapeutic Targets
Kristian Agmund Haanes et al.
CNS DRUGS (2019)
Erenumab in chronic migraine Patient-reported outcomes in a randomized double-blind study
Richard B. Lipton et al.
NEUROLOGY (2019)
New Trends in Migraine Pharmacology: Targeting Calcitonin Gene-Related Peptide (CGRP) With Monoclonal Antibodies
Damiana Scuteri et al.
FRONTIERS IN PHARMACOLOGY (2019)
Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine
Messoud Ashina et al.
CEPHALALGIA (2019)
Recent Advances in Pharmacotherapy for Episodic Migraine
Calvin Chan et al.
CNS DRUGS (2019)
Life With Migraine: Effects on Relationships, Career, and Finances From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
Dawn C. Buse et al.
HEADACHE (2019)
Novel Medications for the Treatment of Migraine
Claire E. J. Ceriani et al.
HEADACHE (2019)
Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions
Messoud Ashina et al.
CEPHALALGIA (2019)
The appropriate dosing of erenumab for migraine prevention after multiple preventive treatment failures: a critical appraisal
Raffaele Ornello et al.
JOURNAL OF HEADACHE AND PAIN (2019)
Migraine progression in subgroups of migraine based on comorbidities Results of the CaMEO Study
Richard B. Lipton et al.
NEUROLOGY (2019)
CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications
David W. Dodick
CEPHALALGIA (2019)
Episodic Migraine Comorbidities: Avoiding Pitfalls and Taking Therapeutic Opportunities
Britany Klenofsky et al.
CURRENT PAIN AND HEADACHE REPORTS (2019)
Erenumab in the prophylaxis of migraine: a profile of its use
Emma H. McCafferty et al.
DRUGS & THERAPY PERSPECTIVES (2019)
Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study
Messoud Ashina et al.
CEPHALALGIA (2018)
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
David W. Dodick et al.
CEPHALALGIA (2018)
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
Jes Olesen
CEPHALALGIA (2018)
Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs
Jonathan Jia Yuan Ong et al.
DRUGS (2018)
CGRP and Migraine: The Role of Blocking Calcitonin Gene-Related Peptide Ligand and Receptor in the Management of Migraine
Kasra Maasumi et al.
DRUGS (2018)
Poor medical care for people with migraine in Europe - evidence from the Eurolight study
Zaza Katsarava et al.
JOURNAL OF HEADACHE AND PAIN (2018)
The Biology of Monoclonal Antibodies: Focus on Calcitonin Gene-Related Peptide for Prophylactic Migraine Therapy
Bianca Raffaelli et al.
NEUROTHERAPEUTICS (2018)
Sleep Disorders and Migraine: Review of Literature and Potential Pathophysiology Mechanisms
Angeliki Vgontzas et al.
HEADACHE (2018)
Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation
Lars Bendtsen et al.
JOURNAL OF HEADACHE AND PAIN (2018)
Cognitive dysfunction and migraine
Doga Vuralli et al.
JOURNAL OF HEADACHE AND PAIN (2018)
Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study
Uwe Reuter et al.
LANCET (2018)
Topiramate in Migraine Prevention: A 2016 Perspective
Stephen D. Silberstein
HEADACHE (2017)
A Real-World Analysis of Migraine: A Cross-Sectional Study of Disease Burden and Treatment Patterns
Janet H. Ford et al.
HEADACHE (2017)
Onabotulinumtoxin A for the management of chronic migraine in current clinical practice: results of a survey of sixty-three Italian headache centers
Cristina Tassorelli et al.
JOURNAL OF HEADACHE AND PAIN (2017)
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
Stewart Tepper et al.
LANCET NEUROLOGY (2017)
A Controlled Trial of Erenumab for Episodic Migraine
Peter J. Goadsby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Physiopathology of Migraine: What Have We Learned from Functional Imaging?
Antonio Russo et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2017)
Sleep in Patients with Chronic Migraine
Chun-Pai Yang et al.
CURRENT PAIN AND HEADACHE REPORTS (2017)
Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: comparisons across randomized controlled studies
Dimos D. Mitsikostas et al.
CURRENT OPINION IN NEUROLOGY (2017)
The impact of cognitive symptoms on migraine attack-related disability
Raquel Gil-Gouveia et al.
CEPHALALGIA (2016)
Shared Genetic Factors Underlie Migraine and Depression
Yuanhao Yang et al.
TWIN RESEARCH AND HUMAN GENETICS (2016)
Cutaneous allodynia as a predictor of migraine chronification
Mark A. Louter et al.
BRAIN (2013)
The Hamilton Rating Scale for Depression: The making of a gold standard'' and the unmaking of a chronic illness, 1960-1980
Michael Worboys
CHRONIC ILLNESS (2013)
Italian guidelines for primary headaches: 2012 revised version
Paola Sarchielli et al.
JOURNAL OF HEADACHE AND PAIN (2012)
Depression and risk of transformation of episodic to chronic migraine
Sait Ashina et al.
JOURNAL OF HEADACHE AND PAIN (2012)
Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society
S. D. Silberstein et al.
NEUROLOGY (2012)
Validation of the Headache Impact Test (HIT-6™) across episodic and chronic migraine
Min Yang et al.
CEPHALALGIA (2011)
A subjective cognitive impairment scale for migraine attacks. The MIG-SCOG: Development and validation
Raquel Gil-Gouveia et al.
CEPHALALGIA (2011)
Increased Prevalence of Sleep Disorders in Chronic Headache: A Case-Control Study
Elisa Sancisi et al.
HEADACHE (2010)
Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers
D. C. Buse et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Current practice and future directions in the prevention and acute management of migraine
Peter J. Goadsby et al.
LANCET NEUROLOGY (2010)
Minimal important differences in the Migraine-Specific Quality of Life Questionnaire (MSQ) version 2.1
J. C. Cole et al.
CEPHALALGIA (2009)
Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults
S. Silberstein et al.
CEPHALALGIA (2008)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
Erik von Elm et al.
LANCET (2007)
Impaired functioning and quality of life in severe migraine: the role of catastrophizing and associated symptoms
K. A. Holroyd et al.
CEPHALALGIA (2007)
Four methods of estimating the minimal important difference score were compared to establish a clinically significant change in Headache Impact Test
RR Coeytaux et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2006)
Headache and sleep: Examination of sleep patterns and complaints in a large clinical sample of migraineurs
L Kelman et al.
HEADACHE (2005)
The joint contribution of physical pathology, pain-related fear and catastrophizing to chronic back pain disability
ML Peters et al.
PAIN (2005)
Comorbidity of migraine and depression - Investigating potential etiology and prognosis
N Breslau et al.
NEUROLOGY (2003)
A six-item short-form survey for measuring headache impact: The HIT-6 (TM)
M Kosinski et al.
QUALITY OF LIFE RESEARCH (2003)
Pain catastrophizing predicts pain intensity, disability, and psychological distress independent of the level of physical impairment
R Severeijns et al.
CLINICAL JOURNAL OF PAIN (2001)
Theoretical perspectives on the relation between catastrophizing and pain
MJL Sullivan et al.
CLINICAL JOURNAL OF PAIN (2001)
Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability
WF Stewart et al.
NEUROLOGY (2001)
分享论文
